Juno Therapeutics

Biotech By Sharon Begley

Beware the hype: Top scientists cautious about fighting cancer with immunotherapy

Health By Rebecca Robbins

For cancer patients on experimental immunotherapy drugs, it’s been an emotional week

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Pharma backs patients, docs who oppose Medicare Part B overhaul

Biotech By Damian Garde

FDA lets cancer trial resume after three patient deaths

Biotech By Sharon Begley

In Juno patient deaths, echoes seen of earlier failed company

Pharmalot By Ed Silverman

Are patient deaths in the Juno cancer trial just a ‘bump in the road’?

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Duchenne drug rejected in US is available in England